Klastersky J, Sculier J P, Mommen P
Med Oncol Tumor Pharmacother. 1985;2(1):11-5. doi: 10.1007/BF02934775.
We studied 241 patients with non small cell bronchogenic cancer who were treated with cisplatin and etoposide or cisplatin, etoposide and vindesine. There were 11 (4.5%) complete responders in these series most of whom had a prolonged survival.
